Challenges with benchmarking of MDMA-assisted psychotherapy
Peer reviewed, Journal article
Published version
Permanent lenke
https://hdl.handle.net/11250/3016871Utgivelsesdato
2021Metadata
Vis full innførselSamlinger
- Institutt for psykologi [2830]
- Publikasjoner fra CRIStin - NTNU [36779]
- Publikasjoner fra Cristin - St. Olavs hospital [1440]
- St. Olavs hospital [2421]
Sammendrag
To represent a treatment breakthrough, 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder (PTSD) should be evaluated against first-line psychological interventions or for prespecified patient subgroups that do not improve after such interventions.